Your trusted source for investing success

Tag: public offering

Are You Aware of the FDA's Plans for 2018?

Find out what's going on in our new report
 

Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock

Aeglea BioTherapeutics (Nasdaq:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer, today announced that it has commenced an underwritten public offering of 4,500,000 shares of its common stock. The offering is subject to market conditions, and there can be

Apellis Pharmaceuticals Announces Proposed Offering of Common Stock

Apellis Pharmaceuticals (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, today announced that it has commenced an underwritten public offering of 5,000,000 shares of its common stock. All of the shares are being offered by

EyeGate Announces $11.25 Million Public Offering

EyeGate Pharmaceuticals (NASDAQ:EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for treating diseases and disorders of the eye, announced today the pricing of a public offering of an aggregate of 35,156,250 shares of common stock (or common stock equivalents) and warrants to purchase an aggregate of 35,156,250

PolarityTE Announces Public Offering of Common Stock

PolarityTE (Nasdaq:COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products for the fields of medicine, biomedical engineering and material sciences, today announced that it has commenced an underwritten public offering of shares of its

Novavax Announces Proposed Public Offering of Common Stock

Novavax (Nasdaq:NVAX), a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases, today announced that it intends to offer to sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. As part of this offering Novavax intends to grant the

Tech Forecast and Promising Tech Stocks To Buy in 2017

Learn about breakthrough technology about to impact lives around the globe. We cover the entire industry in our FREE investor’s report. Gain Access
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Bellicum Pharmaceuticals Announces Pricing of Public Offering of Common Stock

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/bellicum-pharmaceuticals-announces-pricing-public-offering-common-stock/